[EN] PROCESS FOR MAKING TERTIARY AMINOALCOHOL COMPOUNDS<br/>[FR] PROCÉDÉ DE FABRICATION D'AMINOALCOOLS TERTIAIRES
申请人:ANGUS CHEMICAL
公开号:WO2012044508A1
公开(公告)日:2012-04-05
Provided is a process for making a tertiary aminoalcohol compound. The process comprises using an excess amount of a carbonyl compound in a condensation step between the carbonyl compound and a nitroalkane, and conducting a hydrogenation/alkylation step to produce the tertiary aminoalcohol. The process uses fewer steps than conventional processes.
APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES
申请人:AbbVie Inc.
公开号:US20130096121A1
公开(公告)日:2013-04-18
Disclosed are compounds which inhibit the activity of anti-apoptotic Bc1-xL proteins, compositions containing the compounds and methods of treating diseases during which is expressed anti-apoptotic Bc1-xL protein.
[EN] NITRATED HYDROCARBONS, DERIVATIVES, AND PROCESSES FOR THEIR MANUFACTURE<br/>[FR] HYDROCARBURES NITRÉS, DÉRIVÉS ET LEURS PROCÉDÉS DE PRODUCTION
申请人:ANGUS CHEMICAL
公开号:WO2009129097A1
公开(公告)日:2009-10-22
Provided is a process for the formation of nitrated compounds by the nitration of hydrocarbon compounds with dilute nitric acid. Also provided are processes for preparing industrially useful downstream derivatives of the nitrated compounds, as well as novel nitrated compounds and derivatives, and methods of using the derivatives in various applications.
[EN] QUATERNARY AMMONIUM POLYHYDROXYL COMPOUNDS AND THEIR USE IN PERSONAL CARE COMPOSITIONS<br/>[FR] COMPOSÉS POLYHYDROXYLÉS D'AMMONIUM QUATERNAIRE ET LEUR UTILISATION DANS DES COMPOSITIONS DE SOINS PERSONNELS
申请人:DOW GLOBAL TECHNOLOGIES LLC
公开号:WO2012050769A1
公开(公告)日:2012-04-19
Described are novel monocationic polyhydroxyl compounds and their uses in personal care compositions.
描述了一种新型的单阳离子聚羟基化合物及其在个人护理组合物中的用途。
APOPTOSIS-INDUCED AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES
申请人:AbbVie Inc.
公开号:US20160206611A1
公开(公告)日:2016-07-21
Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-xL proteins, compositions containing the compounds and methods of treating diseases during which is expressed anti-apoptotic Bcl-xL protein.